Free shipping on all orders over $ 500

Agomelatine

Cat. No. M2230

All AbMole products are for research use only, cannot be used for human consumption.

Agomelatine Structure
Synonym:

Valdoxan; Melitor; S-20098

Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
10mM*1mL in DMSO USD 50  USD50 In stock
1mg USD 20  USD20 In stock
5mg USD 40  USD40 In stock
10mg USD 70  USD70 In stock
50mg USD 216  USD216 In stock
100mg USD 330  USD330 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Agomelatine is an extremely potent agonist at both melatonin receptors (MT1 and MT2), with additional antagonism at 5HT2C. Agomelatine is a novel antidepressant with many desired in vivo properties, including neuroprotection and neurogenesis in depression-sensitive brain areas. Agomelatine abolishes 5-HT2C agonist effects both in cells and in vivo. 

Agomelatine also dose dependently increases extracellular levels of noradrenaline and dopamine in frontal cortex of freely moving rats. Agomelatine (25, 50, or 75 mg/kg; i.p.) has antioxidant activity in Strychnine (75 mg/kg, i.p.) or Pilocarpine (400 mg/kg, i.p.) induced seizure models in mice. Agomelatine dose not have any antioxidant effects on parameters of oxidative stress produced by Pentylenetetrazole (PTZ) or Picrotoxin (PTX) induced seizure models when compared to controls.

Chemical Information
Molecular Weight 243.3
Formula C15H17NO2
CAS Number 138112-76-2
Solubility (25°C) DMSO 60 mg/mL
Ethanol 20 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] George Konstantakopoulos, et al. The preclinical discovery and development of agomelatine for the treatment of depression

[2] Enrico Smeraldi, et al. Agomelatine in depression

[3] Carlos Clayton Torres Aguiar, et al. Cell Mol Neurobiol. Effects of agomelatine on oxidative stress in the brain of mice after chemically induced seizures

[4] Valerie Audinot, et al. Naunyn Schmiedebergs Arch Pharmacol. New selective ligands of human cloned melatonin MT1 and MT2 receptors

[5] M J Millan, et al. J Pharmacol Exp Ther . The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways

Related Melatonin Receptor Products
DH97 

DH97 is a potent and selective antagonist of MT2 melatonin receptor, with a pKi of 8.03 for human MT2.

8-M-PDOT

8-M-PDOT (AH-002) is a selective melatonin MT2 receptor agonist.

6-Chloromelatonin 

6-Chloromelatonin is a potent melatonin receptor agonist with greater metabolic stability than melatonin.

Melatonin-d4

Melatonin-d4

Piromelatine

Piromelatine (Neu-P11) is a melatonin MT1/MT2 receptor agonist, serotonin 5-HT1A/5-HT1D agonist, and serotonin 5-HT2B antagonist. Piromelatine (Neu-P11) possesses sleep promoting, analgesic, anti-neurodegenerative, anxiolytic and antidepressant potentials. Piromelatine (Neu-P11) also possesses pain-related P2X3, TRPV1, and Nav1.7 channel-inhibition capacities.

  Catalog
Abmole Inhibitor Catalog




Keywords: Agomelatine, Valdoxan; Melitor; S-20098 supplier, Melatonin Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.